Hit enter to search or ESC to close
About us
Therapeutic Areas
HIV
Antimalarials
Hepatitis
Investors
News
Careers
CSR
Contact
Category
Company News
Company News
CiplaQCIL to enter the private market in Uganda
Company News
CiplaQCIL ensures availability of lifesaving ARVs in Botswana
Company News
CiplaQCIL manufacture malaria drug in response to government’s Covid-19 request
Company News
CiplaQCIL to manufacture ARVs for South Africa
Latest Company News
CiplaQCIL to enter the private market in Uganda
August 26, 2020
CiplaQCIL ensures availability of lifesaving ARVs in Botswana
July 20, 2020
CiplaQCIL manufacture malaria drug in response to government’s Covid-19 request
May 10, 2020
About us
Therapeutic Areas
HIV
Antimalarials
Hepatitis
Investors
News
Careers
CSR
Contact
